These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8674043

  • 1. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
    Ferguson AW, Flatow U, MacDonald NJ, Larminat F, Bohr VA, Steeg PS.
    Cancer Res; 1996 Jul 01; 56(13):2931-5. PubMed ID: 8674043
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
    lizuka N, Miyamoto K, Tangoku A, Hayashi H, Hazama S, Yoshino S, Yoshimura K, Hirose K, Yoshida H, Oka M.
    Br J Cancer; 2000 Nov 01; 83(9):1209-15. PubMed ID: 11027435
    [Abstract] [Full Text] [Related]

  • 3. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
    Baba H, Urano T, Okada K, Furukawa K, Nakayama E, Tanaka H, Iwasaki K, Shiku H.
    Cancer Res; 1995 May 01; 55(9):1977-81. PubMed ID: 7728768
    [Abstract] [Full Text] [Related]

  • 4. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS.
    J Natl Cancer Inst; 2005 May 04; 97(9):632-42. PubMed ID: 15870434
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M.
    Br J Cancer; 1999 Oct 04; 81(3):469-75. PubMed ID: 10507772
    [Abstract] [Full Text] [Related]

  • 7. Nm23 and tumour metastasis: basic and translational advances.
    Freije JM, MacDonald NJ, Steeg PS.
    Biochem Soc Symp; 1998 Oct 04; 63():261-71. PubMed ID: 9513729
    [Abstract] [Full Text] [Related]

  • 8. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T, Halverson D, Steeg PS.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
    Miyazaki H, Fukuda M, Ishijima Y, Takagi Y, Iimura T, Negishi A, Hirayama R, Ishikawa N, Amagasa T, Kimura N.
    Clin Cancer Res; 1999 Dec 01; 5(12):4301-7. PubMed ID: 10632374
    [Abstract] [Full Text] [Related]

  • 10. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23.
    Tseng YH, Vicent D, Zhu J, Niu Y, Adeyinka A, Moyers JS, Watson PH, Kahn CR.
    Cancer Res; 2001 Mar 01; 61(5):2071-9. PubMed ID: 11280768
    [Abstract] [Full Text] [Related]

  • 11. Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.
    Martinez R, Venturelli D, Perrotti D, Veronese ML, Kastury K, Druck T, Huebner K, Calabretta B.
    Cancer Res; 1997 Mar 15; 57(6):1180-7. PubMed ID: 9067290
    [Abstract] [Full Text] [Related]

  • 12. High levels of nm23 expression are related to cell proliferation in human prostate cancer.
    Igawa M, Rukstalis DB, Tanabe T, Chodak GW.
    Cancer Res; 1994 Mar 01; 54(5):1313-8. PubMed ID: 8118821
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cell motility after nm23 transfection of human and murine tumor cells.
    Kantor JD, McCormick B, Steeg PS, Zetter BR.
    Cancer Res; 1993 May 01; 53(9):1971-3. PubMed ID: 8481897
    [Abstract] [Full Text] [Related]

  • 14. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
    Chen SL, Wu YS, Shieh HY, Yen CC, Shen JJ, Lin KH.
    Mol Carcinog; 2003 Apr 01; 36(4):204-14. PubMed ID: 12669312
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.
    de la Rosa A, Mikhak B, Steeg PS.
    Arch Med Res; 1996 Apr 01; 27(3):395-401. PubMed ID: 8854401
    [Abstract] [Full Text] [Related]

  • 16. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
    Huijzer JC, McFarland M, Niles RM, Meadows GG.
    J Cell Physiol; 1996 Mar 01; 166(3):487-94. PubMed ID: 8600152
    [Abstract] [Full Text] [Related]

  • 17. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS.
    Cancer Res; 2001 Mar 01; 61(5):2320-7. PubMed ID: 11280805
    [Abstract] [Full Text] [Related]

  • 18. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
    Liu F, Zhang Y, Zhang XY, Chen HL.
    J Cancer Res Clin Oncol; 2002 Apr 01; 128(4):189-96. PubMed ID: 11935309
    [Abstract] [Full Text] [Related]

  • 19. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, Arnaud-Dabernat S, Palmieri D, Stetler-Stevenson WG, Lacombe ML, Meltzer PS, Steeg PS.
    Cancer Res; 2007 Aug 01; 67(15):7238-46. PubMed ID: 17671192
    [Abstract] [Full Text] [Related]

  • 20. DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics.
    Amendola R, Martinez R, Negroni A, Venturelli D, Tanno B, Calabretta B, Raschellà G.
    Med Pediatr Oncol; 2001 Jan 01; 36(1):93-6. PubMed ID: 11464913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.